OBJECTIVE: The objective of this study was to determine the epidemiology of herpes simplex virus type 2 (HSV-2) in general and socially marginalized populations of low-income, urban, coastal Peru. STUDY: Two low-income populations were administered an epidemiologic survey and serologic tests, determining risk behavior, HSV-2, and HIV prevalence. RESULTS: In the socially marginalized population, HSV-2 prevalence was 72.3% in men who have sex only with men (MSOM), 42.5% in women, and 20.7% in men. In the general population, HSV-2 prevalence was 20.5% in women and 7.1% in men. In all groups except the male general population, HSV-2 prevalence increased with age or number of sexually active years (both P <0.001). HSV-2 infection was associated with HIV infection in MSOM (P <0.023) and other socially marginalized men (P <0.01). CONCLUSION: HSV-2 was common in both low-income populations, and control programs are needed in Peru given high prevalence and association with HIV infection. Prevention of HSV-2 infection should target individuals before they become sexually active.
OBJECTIVE: The objective of this study was to determine the epidemiology of herpes simplex virus type 2 (HSV-2) in general and socially marginalized populations of low-income, urban, coastal Peru. STUDY: Two low-income populations were administered an epidemiologic survey and serologic tests, determining risk behavior, HSV-2, and HIV prevalence. RESULTS: In the socially marginalized population, HSV-2 prevalence was 72.3% in men who have sex only with men (MSOM), 42.5% in women, and 20.7% in men. In the general population, HSV-2 prevalence was 20.5% in women and 7.1% in men. In all groups except the male general population, HSV-2 prevalence increased with age or number of sexually active years (both P <0.001). HSV-2 infection was associated with HIV infection in MSOM (P <0.023) and other socially marginalized men (P <0.01). CONCLUSION:HSV-2 was common in both low-income populations, and control programs are needed in Peru given high prevalence and association with HIV infection. Prevention of HSV-2 infection should target individuals before they become sexually active.
Authors: Kelika Anne Konda; Andres G Lescano; Elli Leontsini; Percy Fernandez; Jeffrey D Klausner; Thomas J Coates; Carlos F Cáceres Journal: AIDS Behav Date: 2007-03-22
Authors: Andre Maiorana; Susan Kegeles; Percy Fernandez; Ximena Salazar; Carlos Cáceres; Clara Sandoval; Ana María Rosasco; Thomas Coates Journal: Eval Program Plann Date: 2006-12-04
Authors: Amaya G Perez-Brumer; Catherine E Oldenburg; Katie B Biello; David S Novak; Joshua G Rosenberger; Matthew J Mimiaga Journal: Int J STD AIDS Date: 2015-09-16 Impact factor: 1.359
Authors: Angela M Bayer; Mijail Garvich; David A Díaz; Hugo Sánchez; Patricia J García; Thomas J Coates Journal: Sex Transm Infect Date: 2014-01-03 Impact factor: 3.519
Authors: Victoria Villacorta; Susan Kegeles; Jerome Galea; Kelika A Konda; José Pajuelo Cuba; Carlos F Cáceres Palacios; Thomas J Coates Journal: Clin Trials Date: 2007 Impact factor: 2.486
Authors: Jonathan M Snowden; Kelika A Konda; Segundo R Leon; Jessica M Giron; Guadalupe Escobar; Thomas J Coates; Carlos F Caceres; Jeffrey D Klausner Journal: Sex Transm Dis Date: 2010-02 Impact factor: 2.830
Authors: Carlos F Cáceres; Kelika A Konda; Ximena Salazar; Segundo R Leon; Jeffrey D Klausner; Andrés G Lescano; André Maiorana; Susan Kegeles; Franca R Jones; Thomas J Coates Journal: AIDS Behav Date: 2007-12-27
Authors: Junia Rodrigues; Beatriz Grinsztejn; Francisco I Bastos; Luciane Velasque; Paula M Luz; Claudia T V de Souza; Ingebourg Georg; Jose H Pilotto; Valdilea G Veloso Journal: BMC Infect Dis Date: 2009-04-01 Impact factor: 3.090
Authors: Jesse L Clark; Andres G Lescano; Kelika A Konda; Segundo R Leon; Franca R Jones; Jeffrey D Klausner; Thomas J Coates; Carlos F Caceres Journal: PLoS One Date: 2009-09-25 Impact factor: 3.240